Reduction Mammoplasty and Gynecomastia Surgery
Medical necessity criteria and coding implications for breast reduction (reduction mammoplasty) and surgical treatment of gynecomastia for Centene-affiliated health plans, including documentation requirements and referenced appendices.
Criteria updated to include a medical director review when the weight of resected tissue falls below the 22nd percentile on the Schnur Sliding Scale.
Gynecomastia persistence timeframes aligned with ASPS guidance for adolescents and adults (adolescents: specific durations; adults: >3 months after ruling out causes or unsuccessful medical treatment).
For members/enrollees >= 40 years with symptoms or high-risk factors, a mammogram negative for cancer is required within one year of the planned reduction mammoplasty.
Terminology changed to refer to 'those with a male reproductive system' and 'those with a female reproductive system' throughout criteria and background.
Clarifying language added and several criteria adjusted including mammogram requirement for members/enrollees 40 years with symptoms or high-risk factors, and removal of adult testicular size attainment criterion.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.